{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:24:57Z","timestamp":1772479497253,"version":"3.50.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Dysglycaemia, defined as hypo- or hyperglycaemia, can occur during infection and is associated with worse outcomes during hospitalization. Previous studies on dysglycaemia in non-critically ill patients on general wards used point-of-care (POC) capillary measurements, possibly underestimating the problem. We assessed the prevalence and course of dysglycaemia in this population using continuous glucose monitoring (CGM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, observational study at the University Medical Center Groningen, adults admitted to the Emergency Department with suspected infections were enrolled via the Acutelines data and biobank. Participants wore blinded CGM sensors (FreeStyle Libre Pro iQ) while continuing usual care. Episodes of dysglycaemia were defined as \u226515 minutes of glucose &lt;3.9 mmol\/L or &gt;10 mmol\/L. Primary outcome was the number of dysglycaemic episodes; secondary outcomes included duration, glucose levels, and associations with clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CGM data from 90 participants (27% with a history of diabetes and 73% without) over a median of 3.4 days revealed 181 hyperglycaemia and 303 hypoglycaemia episodes. In patients with a history of diabetes, 75% experienced hyperglycaemia (median of 6.5 events\/patient). In contrast, 33% of individuals without prior diabetes experienced hyperglycaemia (median 1.5 events\/ patient). Median Time in Range (glucose 3.9\u201310.0 mmol\/L) was 59% for patients with and 86% for patients without known diabetes. Exploratory analyses showed no significant association between dysglycaemia and ICU admission or 30-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This observational study provides relevant insight into dysglycaemia among non-critically ill patients admitted to the hospital. Significant hyperglycaemia was observed in both participants with and without known diabetes. Therefore, CGM may enable earlier detection of dysglycaemia and thereby inform future interventional research and in-hospital strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0343703","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:23:11Z","timestamp":1772475791000},"page":"e0343703","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucose dysregulation in hospitalized non-critically ill patients with a suspected infection: A prospective study using continuous glucose monitoring"],"prefix":"10.1371","volume":"21","author":[{"given":"Anna D.","family":"Schoonhoven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-0125","authenticated-orcid":true,"given":"Julia J.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra D.","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarens","family":"van der Vaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riemer","family":"Been","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 P.","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hjalmar R.","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"7","key":"pone.0343703.ref001","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ejim.2014.06.017","article-title":"Acute admissions to medical departments in Denmark: diagnoses and patient characteristics","volume":"25","author":"B Vest-Hansen","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"16","key":"pone.0343703.ref002","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress","volume":"106","author":"K Esposito","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"pone.0343703.ref003","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0749-0704(05)70154-8","article-title":"Stress-induced hyperglycemia","volume":"17","author":"KC McCowen","year":"2001","journal-title":"Crit Care Clin"},{"issue":"19","key":"pone.0343703.ref004","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2174\/138161208784980563","article-title":"Glucose metabolism and insulin resistance in sepsis","volume":"14","author":"SJ Van Cromphaut","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"3","key":"pone.0343703.ref005","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc10-1185","article-title":"Diabetes and sepsis: preclinical findings and clinical relevance","volume":"34","author":"P Schuetz","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0343703.ref006","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/0885066619889322","article-title":"Blood glucose levels and mortality in patients with sepsis: dose-response analysis of observational studies","volume":"36","author":"W Wang","year":"2021","journal-title":"J Intensive Care Med"},{"key":"pone.0343703.ref007","article-title":"Association of blood glucose level and glycemic variability with mortality in sepsis patients during ICU hospitalization","volume":"10","author":"Z Lu","year":"2022","journal-title":"Front Public Health"},{"issue":"4","key":"pone.0343703.ref008","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/diacare.28.4.810","article-title":"The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia","volume":"28","author":"FA McAlister","year":"2005","journal-title":"Diabetes Care"},{"issue":"5","key":"pone.0343703.ref009","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.annemergmed.2011.03.052","article-title":"Diabetes is not associated with increased mortality in emergency department patients with sepsis","volume":"58","author":"P Schuetz","year":"2011","journal-title":"Ann Emerg Med"},{"issue":"4","key":"pone.0343703.ref010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-002880","article-title":"In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19","volume":"10","author":"RD Barmanray","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"pone.0343703.ref011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7861\/clinmed.2019-0255","article-title":"Safe care for people with diabetes in hospital","volume":"20","author":"K Dhatariya","year":"2020","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"pone.0343703.ref012","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"GE Umpierrez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0343703.ref013","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1932296815602905","article-title":"Continuous glucose monitoring versus capillary point-of-care testing for inpatient glycemic control in type 2 diabetes patients hospitalized in the general ward and treated with a basal bolus insulin regimen","volume":"10","author":"AM G\u00f3mez","year":"2015","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"pone.0343703.ref014","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/dia.2012.0282","article-title":"Brief report: comparison of continuous glucose monitoring and finger-prick blood glucose levels in hospitalized patients administered basal-bolus insulin","volume":"15","author":"MG Burt","year":"2013","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"pone.0343703.ref015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.eprac.2023.06.007","article-title":"Accuracy and potential interferences of continuous glucose monitoring sensors in the hospital","volume":"29","author":"V Bellido","year":"2023","journal-title":"Endocr Pract"},{"issue":"11","key":"pone.0343703.ref016","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.2337\/dc19-2073","article-title":"Comparison of the FreeStyle Libre Pro flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with basal-bolus insulin regimen","volume":"43","author":"RJ Galindo","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"pone.0343703.ref017","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2025.0232","article-title":"Real-world accuracy of continuous glucose monitoring during intensive hematological care: a prospective study","volume":"27","author":"M Tienstra","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"pone.0343703.ref018","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.eprac.2024.09.013","article-title":"High frequency of severe hyperglycemia observed during intensive hematologic care: a prospective study using continuous glucose monitoring","volume":"30","author":"M Tienstra","year":"2024","journal-title":"Endocr Pract"},{"issue":"11","key":"pone.0343703.ref019","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2337\/dc20-1016","article-title":"Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a non-ICU hospital setting","volume":"43","author":"AL Fortmann","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"pone.0343703.ref020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/dc24-2222","article-title":"In-hospital diabetes management by a diabetes team and insulin titration algorithms based on continuous glucose monitoring or point-of-care glucose testing in patients with type 2 diabetes (DIATEC): a randomized controlled trial","volume":"48","author":"MT Olsen","year":"2025","journal-title":"Diabetes Care"},{"issue":"4","key":"pone.0343703.ref021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/dia.2023.0390","article-title":"Continuous glucose monitoring systems in noninsulin-treated people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"ROM Ferreira","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"pone.0343703.ref022","doi-asserted-by":"crossref","first-page":"111986","DOI":"10.1016\/j.diabres.2024.111986","article-title":"Use of continuous glucose monitoring and point-of-care glucose testing in hospitalized patients with diabetes mellitus in non-intensive care unit settings: a systematic review and meta-analysis of randomized controlled trials","volume":"220","author":"G Cavalcante Lima Chagas","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"pone.0343703.ref023","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"18","author":"JP Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"issue":"7","key":"pone.0343703.ref024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047349","article-title":"Cohort profile of Acutelines: a large data\/biobank of acute and emergency medicine","volume":"11","author":"E Ter Avest","year":"2021","journal-title":"BMJ Open"},{"issue":"2","key":"pone.0343703.ref025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/cd17-0130","article-title":"Freestyle libre glucose monitoring system.","volume":"36","author":"A Blum","year":"2018","journal-title":"Clin Diabetes"},{"key":"pone.0343703.ref026","unstructured":"Federatie Medisch Specialisten. Richtlijnendatabase- diabetes mellitus; 2014 [Online] [cited 2024 Oct 30]. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/diabetes_mellitus\/diabetes_mellitus_-_startpagina.html"},{"issue":"1","key":"pone.0343703.ref027","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"T Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"pone.0343703.ref028","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1210\/clinem\/dgac278","article-title":"Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an endocrine society clinical practice guideline","volume":"107","author":"MT Korytkowski","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pone.0343703.ref029","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/19322968221137338","article-title":"Continuous glucose monitoring within hospital: a scoping review and summary of guidelines from the joint british diabetes societies for inpatient care","volume":"17","author":"P Avari","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"pone.0343703.ref030","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1177\/19322968231191104","article-title":"A consensus statement for continuous glucose monitoring metrics for inpatient clinical trials","volume":"17","author":"EK Spanakis","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"pone.0343703.ref031","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/dci17-0043","article-title":"Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group","volume":"40","author":"JR Petrie","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"pone.0343703.ref032","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing--when and how?","volume":"54","author":"R Bender","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"pone.0343703.ref033","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"P Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"pone.0343703.ref034","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.chest.2019.05.016","article-title":"Percentage of time in range 70 to 139 mg\/dL is associated with reduced mortality among critically ill patients receiving IV insulin infusion","volume":"156","author":"MJ Lanspa","year":"2019","journal-title":"Chest"},{"issue":"10","key":"pone.0343703.ref035","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/jc.2018-02763","article-title":"Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study","volume":"104","author":"VN Shah","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"pone.0343703.ref036","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/dia.2018.0150","article-title":"Accuracy of a factory-calibrated, real-time continuous glucose monitoring system during 10 days of use in youth and adults with diabetes","volume":"20","author":"RP Wadwa","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"pone.0343703.ref037","article-title":"Accuracy of a professional continuous glucose monitoring device in individuals with type 2 diabetes mellitus","volume":"68","author":"Y Nakagawa","year":"2022","journal-title":"Kobe J Med Sci"},{"issue":"5","key":"pone.0343703.ref038","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2337\/diacare.10.5.622","article-title":"Evaluating clinical accuracy of systems for self-monitoring of blood glucose","volume":"10","author":"WL Clarke","year":"1987","journal-title":"Diabetes Care"},{"issue":"7003","key":"pone.0343703.ref039","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence","volume":"311","author":"DG Altman","year":"1995","journal-title":"BMJ"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:23:17Z","timestamp":1772475797000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343703"}},"subtitle":[],"editor":[{"given":"Hidetaka","family":"Hamasaki","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0343703","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}